• Recruiting

NCT04144387: IFM2017 Evaluation of the Impact of the Update SMM Criteria on the Natural History SMM

Updated: May 23

IFM 2017-04 - CARRISMM


NCT04144387: Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. (CARRISMM)

ifm-2017

IFM 2017-04


CARRISMM IFM 2017-04


Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations. (CARRISMM)


This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.


Sponsor:

Intergroupe Francophone du Myelome

 

ClinicalTrials.gov Identifier: NCT04144387


Official Title: Evaluation of the Impact of the Update Multiple Myeloma Criteria on the Natural History of Smoldering Myeloma in Order to Establish New Recommendations About Follow-up and Prognostic Evaluation of Smoldering Myeloma (CARRISMM)


First Posted: October 30, 2019


Click here to see details on ClinicalTrials.gov

 

Procedure: Myelogram

 

Locations


Europe

Belgium

France

Monaco


Posts Archive